The findings were published Oct. 26 in the Journal of Clinical Oncology. OSU news release. . .
- "It's as if aggressive prostate cancers are growing faster and their blood vessels never fully mature," says study leader Dr. Steven Clinton, professor of medicine and a medical oncologist and prostate cancer specialist at Ohio State's Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute.
"Prostate cancer is very heterogeneous, and we need better tools to predict whether a patient has a prostate cancer that is aggressive, fairly average or indolent in its behavior so that we can better define a course of therapy surgery, chemotherapy, radiotherapy, hormonal treatment, or potentially new drugs that target blood vessels that is specific for each person's type of cancer," Clinton says.
No comments:
Post a Comment